The company announced the results on Saturday, 20 October 2012.

Meanwhile, the BSE Sensex was up 89.15 points or 0.48% to 18,771.46.

On BSE, 86,000 shares were traded in the counter as against average daily volume of 41,561 shares in the past one quarter.

The stock hit a high of Rs 197.10 and a low of Rs 191.10 so far during the day. The stock had hit a 52-week high of Rs 203.35 on 25 September 2012. The stock had hit a 52-week low of Rs 101.15 on 13 December 2011.

The stock had outperformed the market over the past one month till 19 October 2012, rising 1.18% compared with the Sensex's 1.01% rise. The scrip had also outperformed the market in past one quarter, jumping 40.07% as against Sensex's 8.12% rise.

The company has equity capital of Rs 23.75 crore. Face value per share is Rs 2.

Unichem Laboratories is an integrated specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche areas of cardiology, neurology and other orthopadics and anti-infectives.